Daclizumab monoclonal antibody drug. Targets CD25 (alpha subunit of IL-2 receptor on T-cells) and is used in treatment of multiple #186826608
Description
Daclizumab monoclonal antibody drug. Targets CD25 (alpha subunit of IL-2 receptor on T-cells) and is used in treatment of multiple sclerosis. Generic name and stylized antibody representation